تجاوز إلى المحتوى الرئيسي
# العنوان نوع الخبر التاريخ رابط الخبر
98 Safety Signal of Azithromycin and the Risk of Mitral valve incompetence Signal
97 Safety Signal of Azithromycin and the Risk of Myocarditis Signal
96 Safety Signal of Dulaglutide and the Risk of Alopecia Signal
95 Safety Signal of Panitumumab and the Risk of Panniculitis Signal
94 Safety Signal of Teriparatide and the Risk of Shivering Signal
93 Safety Signal of Natalizumab and the Risk of Acute Coronary Syndrome Signal
92 Safety Signal of Imatinib and the Risk of Polyserositis Signal
91 Safety Signal of Donepezil and the Risk of QT prolongation Signal
90 The SFDA Advises to Avoid Using NSAIDs in Pregnancy at 20 Weeks or Later Warning
89 Safety Signal of Dolutegravir and the Risk of Hyperglycemia Signal
Displaying 71 - 80 of 168